New Research Challenges Assumptions About Supervised Injection Site Closures
A comprehensive new study examining the aftermath of supervised injection site closures in Alberta has delivered surprising findings that contradict long-held assumptions about overdose prevention. Published in the prestigious scientific journal Addiction, the research specifically analyzes the closure of Red Deer's overdose prevention site (OPS) and reveals no subsequent increase in client deaths despite widespread predictions to the contrary.
Groundbreaking Methodology Sets Study Apart
What makes this research particularly significant is its innovative approach to data collection and analysis. The study represents the first Canadian investigation of injection site closures using individual-level, linkable administrative health data connected to provincial health-card numbers. This breakthrough became possible after Alberta became the first province to link injection site clients to their health numbers in 2024.
The research examined 381 clients at the Red Deer site that closed on March 31, 2025, alongside 300 clients at a comparable facility in Lethbridge that remained operational. The study period spanned from June 30, 2024, to September 27, 2025, with researchers comparing six months of post-closure data to preceding months.
Contrary Findings Challenge Established Narratives
The study's most striking revelation directly contradicts activist claims that supervised injection sites are essential for preventing overdose deaths. Researchers found no increase in mortality among Red Deer clients following the site's closure, despite the community experiencing a higher prevalence of carfentanil—a highly potent synthetic opioid responsible for more than half of Red Deer's overdose fatalities during the study period.
This finding becomes even more remarkable considering the comparative data from Lethbridge, where the injection site remained open. The two communities were carefully matched for population size, median income, and Indigenous population proportions, making the comparison particularly meaningful for policy analysis.
Research Context and National Implications
The study emerges amid heated national debates about supervised injection facilities, which have faced increasing opposition in communities across Canada. From Toronto and Ottawa to Winnipeg and Montreal, residents have expressed concerns about these sites becoming hubs of crime and disorder, particularly when concentrated in neighborhoods already saturated with social services.
Eleven authors contributed to the research, most affiliated with the Canadian Centre of Recovery Excellence (CoRE), a Calgary-based organization that receives funding from the Government of Alberta. The authors emphasize that while CoRE provided institutional support, the Alberta government was not specifically involved in funding this particular study.
Policy Implications and Future Research Directions
These findings raise important questions about the evidence base supporting current drug policy decisions in Canada. Health Canada and other agencies have traditionally justified supervised injection sites as life-saving interventions, but this new research suggests the relationship between these facilities and mortality outcomes may be more complex than previously understood.
The study's authors acknowledge that while their research provides crucial insights into mortality patterns following site closures, additional investigation is needed to understand other potential impacts on community health, crime rates, and social disorder. The research methodology pioneered in this study—linking individual health data to injection site usage—promises to revolutionize how policymakers evaluate harm reduction strategies moving forward.
As communities across Canada continue to grapple with the opioid crisis and debates about appropriate responses, this research provides evidence that challenges conventional wisdom and suggests the need for more nuanced approaches to addiction and overdose prevention policy.
